When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm to host investor call on May 29 to discuss Phase 3 BOSTON data
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (NASDAQ:KPTI) will host an investor conference call on May 29 at 1:00 p.m. ET, to discuss detailed results from the Phase 3 BOSTON study evaluating once-weekly XPOVIO (selinexor) in combination with once-weekly Velcade (bortezomib) and low-dose dexamethasone (SVd) compared to standard twice-weekly Velcade plus low-dose dexamethasone (Vd) in patients with multiple myeloma who have received one to three prior lines of therapy.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Stocks on the move,